Clinic
Rath, Kalyan
Rath, Kalyan was paid $473K by Medicaid between Aug 2019 and Nov 2024, across 35 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoRATH, KALYAN
JASPER, TX 75951
JASPER, TX 75951
33aNPI1639188147assigned 08/05/2006
33bProvider typeRural Health Clinic/Center
28Total paid$473K
24GClaims20,603
24DCodes billed35
24AFirst – last monthAug 2019 – Nov 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Texas
Rank by total paid#109 of 225
Median peer was paid$428K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 30 | $0.00 | |
| 2020 | 772 | $15K | |
| 2021 | 5,890 | $140K | |
| 2022 | 9,864 | $239K | |
| 2023 | 3,310 | $64K | |
| 2024incomplete | 737 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 3,513 | 2,826 | $123K |
| 87428 | 21% | 1,543 | 1,465 | $100K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 15% | 898 | 876 | $70K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 11% | 730 | 711 | $54K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.2% | 474 | 455 | $34K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.2% | 597 | 537 | $25K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.8% | 979 | 925 | $13K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.5% | 1,283 | 1,218 | $12K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 753 | 685 | $8K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 130 | 115 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 536 | 260 | $7K |
| 87631 | 1.4% | 88 | 79 | $7K |
23 more codes
| 97803 | 1.4% | 2,803 | $7K | |
| 99000 | <1% | 152 | $1K | |
| 87807 | <1% | 123 | $1K | |
| 96160 | <1% | 1,258 | $1K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 190 | $772.40 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 70 | $436.19 |
| 99443 | <1% | 92 | $433.58 | |
| 81025 | <1% | 28 | $208.89 | |
| 81003 | <1% | 26 | $45.14 | |
| 81002 | <1% | 14 | $42.91 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 160 | $38.91 |
| 90632 | <1% | 26 | $0.06 | |
| 90733 | <1% | 13 | $0.05 | |
| 90670 | 0% | 133 | $0.00 | |
| 90473 | 0% | 17 | $0.00 | |
| 90715 | 0% | 14 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 2,723 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 932 | $0.00 |
| 36416 | 0% | 13 | $0.00 | |
| 96161 | 0% | 105 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 129 | $0.00 |
| 90647 | 0% | 40 | $0.00 | |
| 90680 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.